From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Predictors | Full model | Trimmed model | ||
---|---|---|---|---|
Estimate | p-value | Estimate | p-value | |
Intercept | 0.15540 | 0.2192 | 0.23004 | 0.0042 |
Global health status/QoL* | 0.00198 | 0.0180 | 0.00191 | 0.0106 |
Physical functioning* | 0.00463 | < 0.0001 | 0.00478 | < 0.0001 |
Role functioning | 0.00058079 | 0.4512 | NS | NS |
Emotional functioning* | 0.00141 | 0.0696 | 0.00136 | 0.0405 |
Cognitive functioning | −0.00048664 | 0.5075 | NS | NS |
Social functioning | 0.00059878 | 0.3536 | NS | NS |
Fatigue | 0.00016137 | 0.8588 | NS | NS |
Nausea/Vomiting | 0.00041262 | 0.7764 | NS | NS |
Pain* | −0.00249 | 0.0001 | −0.00249 | < 0.0001 |
Dyspnea | 0.00060165 | 0.2879 | NS | NS |
Insomnia | 0.00082466 | 0.1039 | NS | NS |
Appetite loss | −0.00037029 | 0.5885 | NS | NS |
Constipation | −0.00050445 | 0.3468 | NS | NS |
Financial difficulties | 0.00079559 | 0.1187 | NS | NS |
Adjusted R-squared values | 0.6956 | 0.6941 | ||
RMSE indices | 0.165 | 0.165 |